Selmod GmbH develops novel therapies for the treatment of serious fungal infections. Currently there are two lead compounds in pre-clinical development.
Selmod GmbH develops novel therapies for the treatment of serious fungal infections. Currently there are two lead compounds in pre-clinical development.
c/o HB&P Treuhand AG, St. Alban-Anlage 44, 4052 Basel, Switzerland